Engineering Magnetosomes for High-Performance Cancer Vaccination-Reference-Cited by-同舟云学术

Engineering Magnetosomes for High-Performance Cancer Vaccination

Published:2019-04-03 Issue:5 Volume:5 Page:796-807
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Li Feng¹,Nie Weidong¹,Zhang Fan¹,Lu Guihong¹,Lv Chengliang¹,Lv Yanlin²,Bao Weier²³,Zhang Lijun²³,Wang Shuang²,Gao Xiaoyong²,Wei Wei²³^ORCID,Xie Hai-Yan¹^ORCID

Affiliation:

1. School of Life Science, Beijing Institute of Technology, Beijing 100081, P. R. China

2. State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P. R. China

3. University of Chinese Academy of Sciences, Beijing 100049, P. R. China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Chinese Academy of Sciences

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acscentsci.9b00060

Reference40 articles.

1. Translational approaches to treatment-induced symptoms in cancer patients

2. Reducing the toxicity of cancer therapy: recognizing needs, taking action

3. Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles

4. Biomaterial-assisted targeted modulation of immune cells in cancer treatment

5. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy;Microsystems & Nanoengineering;2024-08-20

2. Recent update on biomimetic sensor technology for cancer diagnosis;Talanta Open;2024-08

3. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance;Drug Resistance Updates;2024-07

4. Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy;Exploration;2024-03-28

5. Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment;Molecules;2024-03-25